Login / Signup

Interleukin-17 governs hypoxic adaptation of injured epithelium.

Piotr KoniecznyYue XingIkjot SidhuIpsita SubudhiKody P MansfieldBrandon HsiehDouglas E BiancurSamantha B LarsenMichael CammerDongqing LiNing Xu LandénCynthia LoomisAdriana HeguyAnastasia N TikhonovaAristotelis TsirigosShruti Naik
Published in: Science (New York, N.Y.) (2022)
Mammalian cells autonomously activate hypoxia-inducible transcription factors (HIFs) to ensure survival in low-oxygen environments. We report here that injury-induced hypoxia is insufficient to trigger HIF1α in damaged epithelium. Instead, multimodal single-cell and spatial transcriptomics analyses and functional studies reveal that retinoic acid-related orphan receptor γt + (RORγt + ) γδ T cell-derived interleukin-17A (IL-17A) is necessary and sufficient to activate HIF1α. Protein kinase B (AKT) and extracellular signal-regulated kinase 1/2 (ERK1/2) signaling proximal of IL-17 receptor C (IL-17RC) activates mammalian target of rapamycin (mTOR) and consequently HIF1α. The IL-17A-HIF1α axis drives glycolysis in wound front epithelia. Epithelial-specific loss of IL-17RC, HIF1α, or blockade of glycolysis derails repair. Our findings underscore the coupling of inflammatory, metabolic, and migratory programs to expedite epithelial healing and illuminate the immune cell-derived inputs in cellular adaptation to hypoxic stress during repair.
Keyphrases